Peripheral blood microRNAs and the COVID-19 patient: methodological considerations, technical challenges and practice points

References

• Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Coronavirus Disease (COVID-19). 2020; cited 2020 Sept 27. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019
   Google Scholar
• Shi Y, Wang G, Cai XP, et al. An overview of COVID-19. J Zhejiang Univ Sci B. 2020;21(5):343–360.
   PubMed Web of Science ®Google Scholar
• Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206.
   PubMed Web of Science ®Google Scholar
• Khalili M, Karamouzian M, Nasiri N, et al. Epidemiological characteristics of COVID-19: a systematic review and meta-analysis. Epidemiol Infect. 2020;148:e130
   Web of Science ®Google Scholar
• Li LQ, Huang T, Wang YQ, et al. COVID-19 patients’ clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020;92(6):577–583.
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506.
   PubMed Web of Science ®Google Scholar
• Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–128.
   PubMed Web of Science ®Google Scholar
• Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: prospective observational cohort study. BMJ. 2020;369:m1985
   Google Scholar
• Laing AG, Lorenc A, Del Molino Del Barrio I, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26(10):1623–1635.
   Web of Science ®Google Scholar
• Shen B, Yi X, Sun Y, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020;182(1):59–72.e15.
   PubMed Web of Science ®Google Scholar
• Devaux Y. Transcriptome of blood cells as a reservoir of cardiovascular biomarkers. Biochim Biophys Acta Mol Cell Res. 2017;1864(1):209–216.
   PubMed Web of Science ®Google Scholar
• Qian L, Li Q, Baryeh K, et al. Biosensors for early diagnosis of pancreatic cancer: a review. Transl Res. 2019;213:67–89.
   PubMed Web of Science ®Google Scholar
• Best MG, Sol N, Kooi I, et al. RNA-seq of tumor-educated platelets enables blood-based pan-cancer, multiclass, and molecular pathway cancer diagnostics. Cancer Cell. 2015;28(5):666–676.
   PubMed Web of Science ®Google Scholar
• Wingrove JA, Daniels SE, Sehnert AJ, et al. Correlation of peripheral-blood gene expression with the extent of coronary artery stenosis. Circ Cardiovasc Genet. 2008;1(1):31–38.
   PubMedGoogle Scholar
• Vargas J, Lima JAC, Kraus WE, et al. Use of the corus® CAD gene expression test for assessment of obstructive coronary artery disease likelihood in symptomatic non-diabetic patients. PLoS Curr. 2013;5
   PubMedGoogle Scholar
• Zak DE, Penn-Nicholson A, Scriba TJ, et al. A blood RNA signature for tuberculosis disease risk: a prospective cohort study. Lancet. 2016;387(10035):2312–2322
   PubMed Web of Science ®Google Scholar
• De Gonzalo-Calvo D, Vea A, Bär C, et al. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine? Eur Heart J. 2019;40(20):1643–1650.
   PubMed Web of Science ®Google Scholar
• van den Berg MMJ, Krauskopf J, Ramaekers JG, et al. Circulating microRNAs as potential biomarkers for psychiatric and neurodegenerative disorders. Prog Neurobiol. 2020;185:101732.
   PubMed Web of Science ®Google Scholar
• Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol. 2013;9(9):513–521.
   PubMed Web of Science ®Google Scholar
• Valihrach L, Androvic P, Kubista M. Circulating miRNA analysis for cancer diagnostics and therapy. Mol Aspects Med. 2020;72:100825.
   PubMed Web of Science ®Google Scholar
• De Ronde MWJ, Ruijter JM, Moerland PD, et al. Study design and qPCR data analysis guidelines for reliable circulating miRNA biomarker experiments: a review. Clin Chem. 2018;64(9):1308–1318.
   PubMed Web of Science ®Google Scholar
• Siddiqi HK, Mehra MR. COVID-19 illness in native and immunosuppressed states: a clinical–therapeutic staging proposal. J Heart Lung Transplant. 2020;39(5):405–407.
   PubMed Web of Science ®Google Scholar
• Quaranta MT, Olivetta E, Sanchez M, et al. MiR-146a controls CXCR4 expression in a pathway that involves PLZF and can be used to inhibit HIV-1 infection of CD4+ T lymphocytes. Virology. 2015;478:27–38.
   PubMed Web of Science ®Google Scholar
• Huang J, Wang F, Argyris E, et al. Cellular microRNAs contribute to HIV-1 latency in resting primary CD4 + T lymphocytes. Nat Med. 2007;13(10):1241–1247.
   PubMed Web of Science ®Google Scholar
• Thounaojam MC, Kundu K, Kaushik DK, et al. MicroRNA 155 regulates japanese encephalitis virus-induced inflammatory response by targeting src homology 2-containing inositol phosphatase 1. J Virol. 2014;88(9):4798–4810.
   PubMed Web of Science ®Google Scholar
• Ho BC, Yu IS, Lu LF, et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type i interferon. Nat Commun. 2014;5(1):3344.
   Web of Science ®Google Scholar
• Bandiera S, Pernot S, El Saghire H, et al. Hepatitis C virus-induced upregulation of microRNA miR-146a-5p in hepatocytes promotes viral infection and deregulates metabolic pathways associated with liver disease pathogenesis. J Virol. 2016;90(14):6387–6400.
   PubMed Web of Science ®Google Scholar
• Nazari-Jahantigh M, Wei Y, Noels H, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest. 2012;122(11):4190–4202.
   PubMed Web of Science ®Google Scholar
• Bhatt K, Lanting LL, Jia Y, et al. Anti-inflammatory role of microrna-146a in the pathogenesis of diabetic nephropathy. J Am Soc Nephrol. 2016;27(8):2277–2288.
   PubMed Web of Science ®Google Scholar
• Musilova K, Devan J, Cerna K, et al. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels. Blood. 2018;132(22):2389–2400.
   PubMed Web of Science ®Google Scholar
• Schulte C, Barwari T, Joshi A, et al. Comparative analysis of circulating noncoding rnas versus protein biomarkers in the detection of myocardial injury. Circ Res. 2019;125(3):328–340.
   PubMed Web of Science ®Google Scholar
• Wong LL, Zou R, Zhou L, et al. Combining circulating microRNA and NT-proBNP to detect and categorize heart failure subtypes. J Am Coll Cardiol. 2019;73(11):1300–1313.
   PubMed Web of Science ®Google Scholar
• Grasselli G, Tonetti T, Protti A, et al. Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study. Lancet Respir Med. 2020;19(20):1–8.
   Google Scholar
• Cao J, Zheng Y, Luo Z, et al. Myocardial injury and COVID-19: serum hs-cTnI level in risk stratification and the prediction of 30-day fatality in COVID-19 patients with no prior cardiovascular disease. Theranostics. 2020;10(21):9663–9673.
   PubMed Web of Science ®Google Scholar
• Elshazli RM, Toraih EA, Elgaml A, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: a meta-analysis of 6320 patients. PLoS One. 2020;15(8):e0238160.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhang H, Mu S, et al. Lactate dehydrogenase, an independent risk factor of severe COVID-19 patients: a retrospective and observational study. Aging (Albany NY). 2020;12(12):11245–11258.
   PubMedGoogle Scholar
• Konno M, Koseki J, Asai A, et al. Distinct methylation levels of mature microRNAs in gastrointestinal cancers. Nat Commun. 2019;10(1):3888
   PubMedGoogle Scholar
• Tosar JP, Cayota A. Extracellular tRNAs and tRNA-derived fragments. RNA Biol. 2020;17(8):1149–1167.
   PubMed Web of Science ®Google Scholar
• de Gonzalo-calvo D, Vilades D, Martínez-Camblor P, et al. Circulating microRNAs in suspected stable coronary artery disease: a coronary computed tomography angiography study. J Intern Med. 2019;286(3):341–355.
   PubMed Web of Science ®Google Scholar
• Ebert MS, Sharp PA. Roles for microRNAs in conferring robustness to biological processes. Cell. 2012;149(3):515–524.
   PubMed Web of Science ®Google Scholar
• Belmonte T, Mangas A, Calderon-Dominguez M, et al. Peripheral microRNA panels to guide the diagnosis of familial cardiomyopathy. Transl Res. 2020;218:1–15.
   PubMed Web of Science ®Google Scholar
• de Gonzalo-calvo D, Martínez-Camblor P, Bär C, et al. Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids. Theranostics. 2020;10(19):8665–8676.
   PubMed Web of Science ®Google Scholar
• Bonneau E, Neveu B, Kostantin E, et al. How close are miRNAs from clinical practice? A perspective on the diagnostic and therapeutic market. Electron J Int Fed Clin Chem Lab Med. 2019;30(2):114–127.
   Google Scholar
• Walter E, Dellago H, Grillari J, et al. Cost-utility analysis of fracture risk assessment using microRNAs compared with standard tools and no monitoring in the Austrian female population. Bone. 2018;108:44–54.
   PubMed Web of Science ®Google Scholar
• Robinson EL, da Costa Gomes CP, Potočnjak I, et al. A year in the life of the EU-CardioRNA COST action: CA17129 catalysing transcriptomics research in cardiovascular disease. Noncoding RNA. 2020;6(2):17.
   Web of Science ®Google Scholar
• da Costa Gomes CP, Ágg B, Andova A, et al. Catalyzing transcriptomics research in cardiovascular disease: the CardioRNA COST action CA17129. Noncoding RNA. 2019;5(2):31
   Web of Science ®Google Scholar
• Williams Z, Ben-Dov IZ, Elias R, et al. Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A. 2013;110(11):4255–4260.
   PubMed Web of Science ®Google Scholar
• Bär C, Thum T, De Gonzalo-Calvo D. Circulating miRNAs as mediators in cell-to-cell communication. Epigenomics. 2019;11(2):111–113.
   PubMed Web of Science ®Google Scholar
• Zhang K, Dong C, Chen M, et al. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma. Theranostics. 2020;10(1):411–425.
   PubMed Web of Science ®Google Scholar
• Cheng M, Yang J, Zhao X, et al. Circulating myocardial microRNAs from infarcted hearts are carried in exosomes and mobilise bone marrow progenitor cells. Nat Commun. 2019;10(1):959
   Google Scholar
• Ludwig N, Leidinger P, Becker K, et al. Distribution of miRNA expression across human tissues. Nucleic Acids Res. 2016;44(8):3865–3877.
   PubMed Web of Science ®Google Scholar
• Fehlmann T, Ludwig N, Backes C, et al. Distribution of microRNA biomarker candidates in solid tissues and body fluids. RNA Biol. 2016;13(11):1084–1088.
   PubMed Web of Science ®Google Scholar
• Kaudewitz D, Skroblin P, Bender LH, et al. Association of microRNAs and YRNAs with platelet function. Circ Res. 2016;118(3):420–432.
   PubMed Web of Science ®Google Scholar
• Thomou T, Mori MA, Dreyfuss JM, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542(7642):450–455.
   PubMed Web of Science ®Google Scholar
• de Gonzalo-calvo D, Cenarro A, Garlaschelli K, et al. Translating the microRNA signature of microvesicles derived from human coronary artery smooth muscle cells in patients with familial hypercholesterolemia and coronary artery disease. J Mol Cell Cardiol. 2017;106:55–67.
   PubMed Web of Science ®Google Scholar
• Akhtar MM, Micolucci L, Islam MS, et al. Bioinformatic tools for microRNA dissection. Nucleic Acids Res. 2016;44(1):24–44.
   PubMed Web of Science ®Google Scholar
• Godard P, Van Eyll J. Pathway analysis from lists of microRNAs: common pitfalls and alternative strategy. Nucleic Acids Res. 2015;43(7):3490–3497.
   PubMed Web of Science ®Google Scholar
• Binderup HG, Madsen JS, Helweg Heegaard NH, et al. Quantification of microRNA levels in plasma – impact of preanalytical and analytical conditions. PLoS One. 2018;13(7):e0201069.
   PubMed Web of Science ®Google Scholar
• Tuck MK, Chan DW, Chia D, et al. Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group. J Proteome Res. 2009;8(1):113–117.
   PubMed Web of Science ®Google Scholar
• Wang K, Yuan Y, Cho JH, et al. Comparing the MicroRNA spectrum between serum and plasma. PLoS One. 2012;7(7):e41561. .
   Web of Science ®Google Scholar
• Cui W, Ma J, Wang Y, et al. Plasma miRNA as biomarkers for assessment of total-body radiation exposure dosimetry. PLoS One. 2011;6(8):e22988.
   Web of Science ®Google Scholar
• Moldovan L, Batte K, Wang Y, et al. Analyzing the circulating microRNAs in exosomes/extracellular vesicles from serum or plasma by qRT-PCR. Methods Mol Biol. 2013;1024:129–145.
   PubMedGoogle Scholar
• Pritchard CC, Kroh E, Wood B, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res. 2012;5(3):492–497.
   PubMed Web of Science ®Google Scholar
• Blondal T, Jensby Nielsen S, Baker A, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59(1):S1–S6.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105(30):10513–10518.
   PubMed Web of Science ®Google Scholar
• Vilades D, Martínez-Camblor P, Ferrero-Gregori A, et al. Plasma circular RNA hsa_circ_0001445 and coronary artery disease: performance as a biomarker. Faseb J. 2020;34(3):4403–4414.
   PubMed Web of Science ®Google Scholar
• Mukai N, Nakayama Y, Ishi S, et al. Cold storage conditions modify microRNA expressions for platelet transfusion. PLoS One. 2019;14(7):e0218797.
   Web of Science ®Google Scholar
• Cheng HH, Yi HS, Kim Y, et al. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One. 2013;8(6):e64795
   Web of Science ®Google Scholar
• Heegaard NHH, Carlsen AL, Lilje B, et al. Diurnal variations of human circulating cell-free micro-RNA. PLoS One. 2016;11(8):e0160577.
   Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13(4):423–435.
   PubMed Web of Science ®Google Scholar
• Niculescu LS, Simionescu N, Sanda GM, et al. MiR-486 and miR-92a identified in circulating HDL discriminate between stable and vulnerable coronary artery disease patients. PLoS One. 2015;10(10):e0140958.
   PubMed Web of Science ®Google Scholar
• Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50(4):298–301.
   PubMed Web of Science ®Google Scholar
• McDonald JS, Milosevic D, Reddi HV, et al. Analysis of circulating microRNA: preanalytical and analytical challenges. Clin Chem. 2011;57(6):833–840.
   PubMed Web of Science ®Google Scholar
• Kloten V, Neumann MHD, Di Pasquale F, et al. Multicenter evaluation of circulating plasma microRNA extraction technologies for the development of clinically feasible reverse transcription quantitative PCR and next-generation sequencing analytical work flows. Clin Chem. 2019;65(9):1132–1140.
   PubMed Web of Science ®Google Scholar
• Kim YK, Yeo J, Kim B, et al. Short structured RNAs with low GC content are selectively lost during extraction from a small number of cells. Mol Cell. 2012;46(6):893–895.
   PubMed Web of Science ®Google Scholar
• Levi M, Thachil J, Iba T, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438–e440.
   PubMed Web of Science ®Google Scholar
• Willems M, Moshage H, Nevens F, et al. Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J Virol Methods. 1993;42(1):127–130.
   PubMed Web of Science ®Google Scholar
• Al-Soud WA, Rådström P. Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol. 2001;39(2):485–493.
   PubMed Web of Science ®Google Scholar
• Boeckel JN, Thomé CE, Leistner D, et al. Heparin selectively affects the quantification of micrornas in human blood samples. Clin Chem. 2013;59(7):1125–1127.
   PubMed Web of Science ®Google Scholar
• Kaudewitz D, Lee R, Willeit P, et al. Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. Thromb Haemost. 2013;110(3):609–615.
   PubMed Web of Science ®Google Scholar
• Li S, Zhang F, Cui Y, et al. Modified high-throughput quantification of plasma microRNAs in heparinized patients with coronary artery disease using heparinase. Biochem Biophys Res Commun. 2017;493(1):556–561.
   PubMed Web of Science ®Google Scholar
• Plieskatt JL, Feng Y, Rinaldi G, et al. Circumventing qPCR inhibition to amplify miRNAs in plasma. Biomark Res. 2014;2(1):13.
   PubMedGoogle Scholar
• Johnson ML, Navanukraw C, Grazul-Bilska AT, et al. Heparinase treatment of RNA before quantitative real-time RT-PCR. Biotechniques. 2003;35(6):1140–1144.
   PubMed Web of Science ®Google Scholar
• Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, mortality, bleeding and pathology among patients hospitalized with COVID-19: a single health system study. J Am Coll Cardiol. 2020 August;76:1815–1826.
   Web of Science ®Google Scholar
• Willeit P, Zampetaki A, Dudek K, et al. Circulating MicroRNAs as novel biomarkers for platelet activation. Circ Res. 2013;112(4):595–600.
   PubMed Web of Science ®Google Scholar
• Shi R, Ge L, Zhou X, et al. Decreased platelet miR-223 expression is associated with high on-clopidogrel platelet reactivity. Thromb Res. 2013;131(6):508–513.
   PubMed Web of Science ®Google Scholar
• Searles CD, Weber M, Baker MB, et al. MicroRNA expression profile in CAD patients and the impact of ACEI/ARB. Cardiol Res Pract. 2011;1(1):532915
   Google Scholar
• Sodi R, Eastwood J, Caslake M, et al. Relationship between circulating microRNA-30c with total- and LDL-cholesterol, their circulatory transportation and effect of statins. Clin Chim Acta. 2017;466:13–19.
   PubMed Web of Science ®Google Scholar
• Solayman MH, Langaee TY, Gong Y, et al. Effect of plasma microRNA on antihypertensive response to beta blockers in the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) studies. Eur J Pharm Sci. 2019;131:93–98.
   PubMed Web of Science ®Google Scholar
• Felekkis K, Papaneophytou C. Challenges in using circulating micro-rnas as biomarkers for cardiovascular diseases. Int J Mol Sci. 2020;21(2):561.
   PubMed Web of Science ®Google Scholar
• Zampetaki A, Mayr M. Analytical challenges and technical limitations in assessing circulating MiRNAs. Thromb Haemost. 2012;108(4):592–598.
   PubMed Web of Science ®Google Scholar
• Moldovan L, Batte KE, Trgovcich J, et al. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 2014;18(3):371–390.
   PubMed Web of Science ®Google Scholar
• Fernández-Sanjurjo M, De Gonzalo-Calvo D, Fernández-Garciá B, et al. Circulating microRNA as emerging biomarkers of exercise. Exerc Sport Sci Rev. 2018;46(3):160–171.
   PubMed Web of Science ®Google Scholar
• Andersen CL, Jensen JL, Ørntoft TF. Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 2004;64(15):5245–5250.
   PubMed Web of Science ®Google Scholar
• Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002;3(7):research0034.1.
   PubMed Web of Science ®Google Scholar
• Kok MGM, de Ronde MWJ, Moerland PD, et al. Small sample sizes in high-throughput miRNA screens: a common pitfall for the identification of miRNA biomarkers. Biomol Detect Quantif. 2018;15:1–5.
   PubMedGoogle Scholar